Recent Finacing
Recent Raise
Perceive Biotherapeutics develops small-molecule, neuroprotective ophthalmology therapeutics using genomic and retina-cell screening to advance glaucoma and geographic atrophy/AMD programs to clinical development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Perceive Biotherapeutics.
